Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Jason O'byrne

CFO at Vir Biotechnology, Inc. (VIR)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $69K

Reported trades

Filed Stock Type Shares Price Value Since
Feb 26SEC VIRVir Biotechnology, Inc. Sell Plan 1,634162,615 held (−1%) $9.53 $16K +4.5%
Feb 24SEC VIRVir Biotechnology, Inc. Sell Plan 2,089164,249 held (−1%) $7.45 $16K +33.7%
Nov 18SEC VIRVir Biotechnology, Inc. Sell Plan 6,799110,701 held (−6%) $5.56 $38K +79.1%
  • Sell

    CFO Jason O'byrne sold $16K of VIR at $9.53 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Jason O'byrne sold $16K of VIR at $7.45 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Jason O'byrne sold $38K of VIR at $5.56 — pre-scheduled 10b5-1 plan sale.